OUTSOURCED PHARMA CAPACITY UPDATE LARGE MOLECULE VIDEOS

12:16 Cytovance-Capabilities-Update-October-2026-Large-Molecule
Cytovance Capabilities Update October 2026: Large Molecule

Move biologics from research and development toward commercialization with integrated development, analytics, scalable GMP manufacturing, and early-phase fill-finish capabilities.

21:15 lonza biologics drug substance october 2026
Lonza Capabilities Update October 2026: Large Molecule

Ben Neunstoecklin, Director of Commercial Development, provides an overview of biologics drug substance manufacturing capabilities and global network capacity that supports customer programs from development through commercial supply.

21:51 Novartis Capabilities Update October 2026: Large Molecule
Novartis Capabilities Update October 2026: Large Molecule

Reliable biologics manufacturing starts with experienced teams, proven tech transfer, and global capacity that scales from clinic to commercial.

20:16 Coriolis Pharma Capabilities Update October 2026: Large Molecule
Coriolis Pharma Capabilities Update October 2026: Large Molecule

Integrated drug product development helps biopharma teams identify risks early, optimize formulation and manufacturing, and create stable, scalable biologics ready for clinical and commercial success.

21:12 3PBiovian Capabilities Update October 2026: Large Molecule
3PBiovian Capabilities Update October 2026: Large Molecule

Integrated CDMO services for biologics and advanced therapies, offering plasmid DNA, viral vectors, fill-finish, and scalable manufacturing from development through commercialization.

11:20 Rentschler-Bio-July-OPCU
Rentschler Biopharma Capabilities Update July 2026: Large Molecule

At Rentschler Biopharma, we help biopharma innovators advance complex large molecule programs from development through commercial manufacturing.

17:13 Avid Bio July OPCU
Avid Bioservices Capabilities Update July 2026: Large Molecule

Discover how integrated development and manufacturing can reduce risk, speed timelines, and support seamless progression from early development to commercial production.

12:11 samsung opcu july large molecule
Samsung Biologics Capabilities Update July 2026: Large Molecule

We offer end-to-end CDMO services across drug substance, drug product, ADC, mRNA, and organoid modalities, with 845,000L capacity and a 99% batch success rate. Evaluate your multi-plant sourcing framework now.

19:34 KBI BioPharma Capabilities Update July 2026: Large Molecule
KBI BioPharma Capabilities Update July 2026: Large Molecule

Combining targeted transposon tech with stable bulk pool generation accelerates cell line development, enabling early material production and fast-tracking candidate selection for clinical entry.

19:14 AbbVie Capabilities Update July 2026: Large Molecule
AbbVie Capabilities Update July 2026: Large Molecule

Integrated manufacturing networks de-risk biopharmaceutical scale-up. Flexible mammalian platforms and advanced ADC conjugation ensure strict quality standards and long-term commercial supply.

16:29 Resilience Capabilities Update May 2026 Large Molecule
Resilience Capabilities Update May 2026: Large Molecule

An integrated network unites biologics, cell therapy, and drug product with digital systems and teams to speed tech transfer, scale reliably, and ensure delivery from development to commercial.

14:20 Rentschler Biopharma Capabilities Update May 2026 Large Molecule
Rentschler Biopharma Capabilities Update May 2026: Large Molecule

Rentschler Biopharma is a global leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. 

18:31 samsung expanding global capacity
Samsung Biologics Capabilities Update May 2026: Large Molecule

Watch this on-demand session to explore the future of global biologics manufacturing, dual-sourcing strategies, and next-generation expansion plans in advanced therapies.

16:44 rezon bio integrated biologics
Rezon Bio Capabilities Update May 2026: Large Molecule

Discover how tailored biologics development strategies can improve scalability, reduce tech transfer risk, and create more reliable pathways from early development to commercial supply.

14:34 Alcami Beyond Capacity
Alcami Capabilities Update May 2026: Large Molecule

Watch this on-demand session to learn risk-based strategies for optimizing biologic drug substance-to-product transitions while minimizing aggregation and process stress.

16:45 cytovance large mol opcu march 26
Cytovance Biologics Capabilities Update March 2026: Large Molecule

How a seasoned development and manufacturing team blends technical depth, reliability, and flexible support to advance large‑molecule programs amid shifting timelines, costs, and regulatory demands.

12:54 fujifilm-biotechnologies-capabilities-update-march-large-molecule
Fujifilm Biotechnologies Capabilities Update March 2026: Large Molecule

An overview of manufacturing strategies and scaling options shows how aligned systems, smart planning, and flexible models support biologics from early development to commercialization.

22:40 probio-capabilities-update-march-large-molecule
ProBio Capabilities Update March 2026: Large Molecule

A new Center of Excellence expands capacity for genetic‑medicine programs with upgraded facilities, streamlined workflows, and early‑stage services that support readiness for PD and IND milestones.

18:55 boehringer-ingelheim-capabilities-update-march-2026-large-molecule
Boehringer Ingelheim Capabilities Update March 2026: Large Molecule

Integrated culture and fermentation systems streamline development, improve scalability, and strengthen continuity throughout the lifecycle of complex biopharmaceutical programs.

18:10 catalent opcu large jan
Leveraging Advanced Tech, Proven Expertise From Cell Line Development And Beyond

Learn how our expertise and advanced capabilities provide customized analytical solutions that ensure quality, precision, and regulatory compliance for your biotherapeutics.

19:17 Cytovance LMD
Cytovance Capacity Update July 2024: Large Molecule Development

Centrally located in the United States, with a decades-long history in biologics development and manufacturing, Cytovance delivers ingenuity end-to-end to both large pharma and biotech clients alike.

Agenda & Presenter Details

Visit our registration pages to see the current agenda and our list of presenting sponsors.

How can we help?

Are you a supplier looking to present at our next event?

Become A Presenter